Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red network_comparison green
Results: HTML CSV LaTeX Showing element 501 to 550 of 66312 in total
Filtered: 1
\def\wcA{0.11111111111111\textwidth} \def\wcB{0.11111111111111\textwidth} \def\wcC{0.11111111111111\textwidth} \def\wcD{0.11111111111111\textwidth} \def\wcE{0.11111111111111\textwidth} \def\wcF{0.11111111111111\textwidth} \def\wcG{0.11111111111111\textwidth} \def\wcH{0.11111111111111\textwidth} \begin{longtable}{|c|c|c|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Value Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Network Comparison Type\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent Interaction Map\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent green\vspace{3pt}}\\ \hline \hline \multirow{12}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 32\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent guanine nucleotide-binding protein g(i), alpha-2 subunit (adenylate cyclase-inhibiting g alpha protein). [source:swissprot;acc:p04899]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Ranked\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 267.142\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 68.932\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 336.074\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-5 like subunit. [source:swissprot;acc:q9y3k8]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Measured\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent Divided\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 1834.73\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 2.04793\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 895.893\vspace{3pt}}\\\cline{2-2}\cline{4-8} &\parbox{\wcB}{\vspace{3pt}\noindent implantation-associated protein. [source:refseq;acc:nm\_032121]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 3278\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1780.5\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 5058.5\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent melanoma-associated antigen 2 (mage-2 antigen). [source:swissprot;acc:p43356]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Squared\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Divided\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 82347.8\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.33073\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 61881.5\vspace{3pt}}\\\cline{2-8} &\parbox{\wcB}{\vspace{3pt}\noindent melanoma-associated antigen 4 (mage-4 antigen) (mage-x2) (mage-41). [source:swissprot;acc:p43358]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 23693.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 5430.7\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 18263\vspace{3pt}}\\\cline{2-8} &\parbox{\wcB}{\vspace{3pt}\noindent mitochondrial solute carrier protein. [source:refseq;acc:nm\_145305]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Rooted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 145.551\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.1597\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 168.796\vspace{3pt}}\\\cline{2-3}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent nuclear dna-binding protein; small unique nuclear receptor corepressor; c1d dna-binding protein. [source:refseq;acc:nm\_006333]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Measured\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent 36360.3\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.19275\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 43368.8\vspace{3pt}}\\\cline{2-8} &\parbox{\wcB}{\vspace{3pt}\noindent pantothenate kinase 1 (ec 2.7.1.33) (pantothenic acid kinase 1) (hpank1) (hpank). [source:swissprot;acc:q8te04]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Squared\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 106226\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 85915\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 192141\vspace{3pt}}\\\cline{2-8} &\parbox{\wcB}{\vspace{3pt}\noindent protein kinase, interferon-inducible double stranded rna dependent activator; protein activator of the interferon-induced protein kinase. [source:refseq;acc:nm\_003690]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Ranked\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 273.188\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.17505\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 232.49\vspace{3pt}}\\\cline{2-2}\cline{4-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent regulator of g-protein signaling 12 (rgs12). [source:swissprot;acc:o14924]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 247.768\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 27.927\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 219.841\vspace{3pt}}\\\cline{2-2}\cline{4-8} &\parbox{\wcB}{\vspace{3pt}\noindent serine/threonine protein phosphatase 2a, 55 kda regulatory subunit b, gamma isoform (pp2a, subunit b, b-gamma isoform) (pp2a, subunit b, b55-gamma isoform) (pp2a, subunit b, pr55-gamma isoform) (pp2a, subunit b, r2-gamma isoform) (imypno1). [source:swissprot;acc:q9y2t4]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 187.462\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.29985\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 243.673\vspace{3pt}}\\\cline{2-8} &\parbox{\wcB}{\vspace{3pt}\noindent tob2 protein (transducer of erbb-2 2). [source:swissprot;acc:q14106]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Rooted\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 38.4152\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 10.7377\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 49.1529\vspace{3pt}}\\\cline{1-3}\cline{6-8} \multirow{16}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 33\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent ba127l20.1 (novel glutathione-s-transferase). [source:sptrembl;acc:q9h4y5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Ranked\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent 228.147\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 27.597\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 200.55\vspace{3pt}}\\\cline{2-3}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent cysteine endopeptidase aut-like isoform b. [source:refseq;acc:nm\_178326]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Squared\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent 77316.3\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 20794.2\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 56522.1\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent dual specificity mitogen-activated protein kinase kinase 4 (ec 2.7.1.-) (map kinase kinase 4) (jnk activating kinase 1) (c-jun n- terminal kinase kinase 1) (jnkk) (sapk/erk kinase 1) (sek1). [source:swissprot;acc:p45985]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Ranked\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent Divided\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 210.241\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.17068\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 246.125\vspace{3pt}}\\\cline{2-2}\cline{4-8} &\parbox{\wcB}{\vspace{3pt}\noindent guanine nucleotide-binding protein g(i), alpha-1 subunit (adenylate cyclase-inhibiting g alpha protein). [source:swissprot;acc:p04898]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 267.144\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 68.929\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 336.073\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-11 subunit. [source:swissprot;acc:p50152]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Measured\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent 1835.3\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 2.04611\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 896.972\vspace{3pt}}\\\cline{2-3}\cline{5-8} &\parbox{\wcB}{\vspace{3pt}\noindent hepatocellular carcinoma-associated protein hca1. [source:refseq;acc:nm\_020932]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Squared\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 82347.8\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.33073\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 61881.5\vspace{3pt}}\\\cline{2-8} &\parbox{\wcB}{\vspace{3pt}\noindent melanoma-associated antigen 9 (mage-9 antigen). [source:swissprot;acc:p43362]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Measured\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 23693.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 5430.7\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 18263\vspace{3pt}}\\\cline{2-3}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent pantothenate kinase 2, mitochondrial precursor (ec 2.7.1.33) (pantothenic acid kinase 2) (hpank2). [source:swissprot;acc:q9bz23]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Squared\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent 106226\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 85915\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 192141\vspace{3pt}}\\\cline{2-3}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent protein kinase, interferon-inducible double stranded rna dependent activator; protein activator of the interferon-induced protein kinase. [source:refseq;acc:nm\_003690]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Rooted\vspace{3pt}}}&&&\parbox{\wcF}{\vspace{3pt}\noindent 25.6987\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 17.8623\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 43.561\vspace{3pt}}\\\cline{2-2}\cline{4-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent protein phosphatase 1, regulatory (inhibitor) subunit 14c; serologically defined breast cancer antigen ny-br-81; pkc-potentiated pp1 inhibitory protein. [source:refseq;acc:nm\_030949]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent 26.0288\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.65937\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 43.1914\vspace{3pt}}\\\cline{2-2}\cline{5-8} &\parbox{\wcB}{\vspace{3pt}\noindent retinoblastoma-associated factor 600. [source:refseq;acc:nm\_020765]\vspace{3pt}}&&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 76.5734\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.15738\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 88.6244\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent septin 6. [source:swissprot;acc:q14141]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 13005.8\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1767.9\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 14773.7\vspace{3pt}}\\\cline{2-8} &\parbox{\wcB}{\vspace{3pt}\noindent serine/threonine protein phosphatase 2a, 65 kda regulatory subunit a, beta isoform (pp2a, subunit a, pr65-beta isoform) (pp2a, subunit a, r1-beta isoform). [source:swissprot;acc:p30154]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Ranked\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 188.688\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.28647\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 242.742\vspace{3pt}}\\\cline{2-3}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent spermatogenesis associated 6. [source:refseq;acc:nm\_019073]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Squared\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent 9924.76\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 2.53372\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 25146.6\vspace{3pt}}\\\cline{2-8} &\parbox{\wcB}{\vspace{3pt}\noindent tob1 protein (transducer of erbb-2 1). [source:swissprot;acc:p50616]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Rooted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 38.5678\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 10.6955\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 49.2633\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent vitelliform macular dystrophy 2-like protein 1. [source:refseq;acc:nm\_017682]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Measured\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent 36360.3\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.19275\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 43368.8\vspace{3pt}}\\\cline{1-3}\cline{5-8} \multirow{16}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 34\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent amp deaminase 2 (ec 3.5.4.6) (amp deaminase isoform l). [source:swissprot;acc:q01433]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Squared\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 9924.76\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 2.53372\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 25146.6\vspace{3pt}}\\\cline{2-8} &\parbox{\wcB}{\vspace{3pt}\noindent bcl2-related ovarian killer. [source:refseq;acc:nm\_032515]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Rooted\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 50.6099\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 10.6492\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 61.2591\vspace{3pt}}\\\cline{2-3}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent cyclic-amp-dependent transcription factor atf-3 (activating transcription factor 3). [source:swissprot;acc:p18847]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Measured\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent 5492.04\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1758.96\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 7251\vspace{3pt}}\\\cline{2-3}\cline{5-8} &\parbox{\wcB}{\vspace{3pt}\noindent gaba-a receptor-associated protein. [source:sptrembl;acc:q9by60]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Rooted\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent High confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 140.508\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 17.63\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 122.878\vspace{3pt}}\\\cline{2-3}\cline{5-8} &\parbox{\wcB}{\vspace{3pt}\noindent glutathione transferase omega 1 (ec 2.5.1.18) (gsto 1-1). [source:swissprot;acc:p78417]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Ranked\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 227.371\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 26.839\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 200.532\vspace{3pt}}\\\cline{2-2}\cline{5-8} &\parbox{\wcB}{\vspace{3pt}\noindent guanine nucleotide-binding protein g(k), alpha subunit (g(i) alpha-3). [source:swissprot;acc:p08754]\vspace{3pt}}&&&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 267.144\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 68.929\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 336.073\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent guanine nucleotide-binding protein g(y), alpha subunit (alpha-11). [source:swissprot;acc:p29992]\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent Measured\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent 1836.71\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 2.02382\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 907.546\vspace{3pt}}\\\cline{3-3}\cline{6-8} &&\parbox{\wcC}{\vspace{3pt}\noindent Rooted\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent 40.2812\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.65305\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 24.3678\vspace{3pt}}\\\cline{2-8} &\parbox{\wcB}{\vspace{3pt}\noindent melanoma antigen, family d, 4 isoform 1; mage1 protein; mage-e1 protein; maged4 protein. [source:refseq;acc:nm\_030801]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Squared\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 82347.8\vspace{3pt}}}&\parbox{\wcG}{\vspace{3pt}\noindent 20466.3\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcH}{\vspace{3pt}\noindent 61881.5\vspace{3pt}}}\\\cline{2-2}\cline{4-4}\cline{7-7} &\parbox{\wcB}{\vspace{3pt}\noindent melanoma-associated antigen 6 (mage-6 antigen) (mage3b). [source:swissprot;acc:p43360]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent Divided\vspace{3pt}}&&&\parbox{\wcG}{\vspace{3pt}\noindent 1.33073\vspace{3pt}}&\\\cline{2-8} &\parbox{\wcB}{\vspace{3pt}\noindent melanoma-associated antigen 8 (mage-8 antigen). [source:swissprot;acc:p43361]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Measured\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 23693.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 5430.7\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 18263\vspace{3pt}}\\\cline{2-3}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent pantothenate kinase 3 (ec 2.7.1.33) (pantothenic acid kinase 3) (hpank3). [source:swissprot;acc:q9h999]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Squared\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent 106226\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 85915\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 192141\vspace{3pt}}\\\cline{2-8} &\parbox{\wcB}{\vspace{3pt}\noindent protein cgi-126 (protein hspc155). [source:swissprot;acc:q9y3c8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Measured\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 5339.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.1897\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 6352.4\vspace{3pt}}\\\cline{2-3}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent putative glialblastoma cell differentiation-related; putative glialblastoma cell differentiation-related protein. [source:refseq;acc:nm\_016172]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Ranked\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent 155.56\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.16197\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 133.876\vspace{3pt}}\\\cline{2-3}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent putative rna-binding protein 7 (rna binding motif protein 7). [source:swissprot;acc:q9y580]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Rooted\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent 49.0544\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.15698\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 56.755\vspace{3pt}}\\\cline{2-3}\cline{5-8} &\parbox{\wcB}{\vspace{3pt}\noindent serine/threonine protein phosphatase 2a, 65 kda regulatory subunit a, alpha isoform (pp2a, subunit a, pr65-alpha isoform) (pp2a, subunit a, r1-alpha isoform) (medium tumor antigen-associated 61 kda protein). [source:swissprot;acc:p30153]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Ranked\vspace{3pt}}&&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 189.07\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.28235\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 242.453\vspace{3pt}}\\\cline{1-3}\cline{6-8} \multirow{6}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 35\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent 28s ribosomal protein s17, mitochondrial precursor (mrp-s17) (hspc011). [source:swissprot;acc:q9y2r5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Squared\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent 106226\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.80879\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 192141\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent apg3p; pc3-96 protein. [source:refseq;acc:nm\_022488]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Rooted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent 140.508\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 17.63\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 122.878\vspace{3pt}}\\\cline{2-3}\cline{5-8} &\parbox{\wcB}{\vspace{3pt}\noindent cytoplasmic polyadenylation element binding protein 3. [source:refseq;acc:nm\_014912]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Ranked\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent Low confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 267.448\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 26.626\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 240.822\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent deoxyribonuclease ii beta isoform 1 precursor; deoxyribonuclease ii beta; endonuclease dlad. [source:refseq;acc:nm\_021233]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Divided\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 33111.4\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 1.18866\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 39358.1\vspace{3pt}}\\\cline{2-8} &\parbox{\wcB}{\vspace{3pt}\noindent guanine nucleotide-binding protein beta subunit 5 (transducin beta chain 5). [source:swissprot;acc:o14775]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Ranked\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent High confidence\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent 267.636\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 67.723\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 335.359\vspace{3pt}}\\\cline{2-4}\cline{6-8} &\parbox{\wcB}{\vspace{3pt}\noindent guanine nucleotide-binding protein g(q), alpha subunit. [source:swissprot;acc:p50148]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent Divided\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent 1836.71\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent 2.02378\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent 907.564\vspace{3pt}}\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/